RNA Dominance in Human Disease
RNA 在人类疾病中的主导地位
基本信息
- 批准号:7600482
- 负责人:
- 金额:$ 29.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-04-01 至 2010-08-14
- 项目状态:已结题
- 来源:
- 关键词:3&apos Untranslated RegionsAdultAffectAllelesAlternative SplicingAntibodiesAppearanceBehavioralBenign congenital hypotoniaBindingBinding ProteinsBinding SitesBiochemicalBiological AssayBrainCardiacCataractCell NucleusCharacteristicsComplexDefectDevelopmentDiseaseDouble-Stranded RNAEmbryoEmbryonic DevelopmentEventExonsFamilyFluorescent in Situ HybridizationFunctional RNAGenesGenomicsGoalsGrantHumanImmunofluorescence ImmunologicImmunoprecipitationInfantInheritedIntronsKnock-outKnockout MiceLengthLimb structureLinkMental RetardationMicrosatellite RepeatsModelingMolecularMonoclonal AntibodiesMusMuscleMuscle DevelopmentMuscle hypotoniaMuscle relaxation phaseMuscular DystrophiesMutationMyoblastsMyotoniaMyotonic DystrophyNeonatalNervous system structureNeuromuscular DiseasesNuclear RNAPathogenesisPatternPhenotypePlasmidsProceduresProcessProtein FamilyProtein IsoformsProteinsRNARNA ProcessingRNA SplicingRNA-Binding ProteinsRecruitment ActivityRegulationReportingResearchResearch PersonnelReverse Transcriptase Polymerase Chain ReactionRoleSiteStagingStructureTestingTissuesTranscriptTransfectionTransgenesTransgenic MiceTransgenic Modelbasecrosslinkearly onsetgain of functionhuman diseaseloss of functionmRNA Precursormouse modelmutantmyogenesisneurogenesisnovelnovel therapeuticsoverexpressionpostnatalpreventprogramswasting
项目摘要
DESCRIPTION (provided by applicant): Although myotonic dystrophy (DM) is the most prevalent muscular dystrophy in adults, a more severe form of this neuromuscular disease is congenital DM (COM). While the two characterized types of adult-onset DM, DM1 and DM2, are caused by unstable microsatellite (CTG)n and (CCTG)n expansions in the DMPK and ZNF9 genes, respectively, CDM is only associated with >1,000 CTG repeats in the DMPK gene. The longterm goals of the proposed research are to elucidate the molecular events which result in CDM and use this information to develop novel therapeutic strategies for this disease. According to the RNA dominance model, DM is an RNA gain-of-function disease in which mutant DMPK and ZNF9 RNAs are retained in the nucleus where they inhibit the functions of the muscleblind-like (MBNL) proteins. MBNL proteins are alternative splicing factors and current evidence suggests that DM disease is caused by the retention of neonatal protein isoforms in the adult. The objective of this proposal is to use both knockout and transgenic mouse models to extend the RNA dominance model to CDM using four experimental aims. First, the hypothesis that specific Mbnl proteins are sequestered during embryogenesis by (CUG)n expansions will be tested using a new transgenic mouse model for CDM. Second, CDM is characterized by neonatal hypotonia and mental retardation so potential roles for Mbnl proteins in the regulation of pre-mRNA processing during embryonic muscle and brain development will be investigated. Third, CDM is only associated with DMPK CTG repeat expansions and previous studies have reported changes in the expression of DMPK, as well as the linked genes DMWD and SIX5, in CDM. Therefore, several mouse knockout lines will be generated to test the hypothesis that CDM results from coordinate loss of MBNL and one, or several, of these DMPK associated genes. Fourth, overexpression of DMPK RNA inhibits myogenic differentiation so the hypothesis that CDM results from co-sequestration of MBNL and DMPK RNA-binding proteins will be evaluated.
描述(由申请人提供):虽然肌强直性营养不良(DM)是成人中最常见的肌肉营养不良,但这种神经肌肉疾病的更严重形式是先天性DM (COM)。虽然两种典型的成人发病型糖尿病DM1和DM2分别是由DMPK和ZNF9基因中不稳定微卫星(CTG)n和(CCTG)n扩增引起的,但CDM仅与DMPK基因中CTG重复数的1000倍相关。提出的研究的长期目标是阐明导致CDM的分子事件,并利用这些信息开发新的治疗策略。根据RNA优势模型,糖尿病是一种RNA功能获得性疾病,其中突变的DMPK和ZNF9 RNA保留在细胞核中,在那里它们抑制了肌盲样(MBNL)蛋白的功能。MBNL蛋白是一种可选择的剪接因子,目前的证据表明,糖尿病是由新生儿蛋白同种异构体在成人体内的保留引起的。本提案的目的是利用敲除和转基因小鼠模型,通过四个实验目的将RNA优势模型扩展到CDM。首先,我们将使用一种新的CDM转基因小鼠模型来验证特异性Mbnl蛋白在(CUG)n扩增过程中被隔离的假设。其次,CDM以新生儿张力低下和智力低下为特征,因此Mbnl蛋白在胚胎肌肉和大脑发育过程中调控pre-mRNA加工的潜在作用将被研究。第三,CDM仅与DMPK CTG重复扩增相关,先前的研究报道了CDM中DMPK以及相关基因DMWD和SIX5的表达变化。因此,将产生几个小鼠敲除系来验证CDM是由MBNL和这些DMPK相关基因中的一个或几个的坐标丢失引起的假设。第四,DMPK RNA的过表达抑制了肌源性分化,因此CDM是由MBNL和DMPK RNA结合蛋白共同隔离引起的假说将被评估。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MAURICE SCOTT SWANSON其他文献
MAURICE SCOTT SWANSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MAURICE SCOTT SWANSON', 18)}}的其他基金
Therapeutic strategies for microsatellite expansion diseases using RNA-targeting CRISPR/Cas
使用 RNA 靶向 CRISPR/Cas 治疗微卫星扩增疾病的策略
- 批准号:
10171924 - 财政年份:2017
- 资助金额:
$ 29.74万 - 项目类别:
Therapeutic strategies for microsatellite expansion diseases using RNA targeting
利用 RNA 靶向治疗微卫星扩增疾病的策略
- 批准号:
10588064 - 财政年份:2017
- 资助金额:
$ 29.74万 - 项目类别:
MECHANISMS OF RNA-MEDIATED CNS PATHOGENESIS IN MYOTONIC DYSTOPHY
RNA介导的强直性肌营养不良中枢神经系统发病机制
- 批准号:
8609101 - 财政年份:2008
- 资助金额:
$ 29.74万 - 项目类别:
MECHANISMS OF RNA-MEDIATED CNS PATHOGENESIS IN MYOTONIC DYSTOPHY
RNA介导的强直性肌营养不良中枢神经系统发病机制
- 批准号:
9105456 - 财政年份:2008
- 资助金额:
$ 29.74万 - 项目类别:
MECHANISMS OF RNA-MEDIATED CNS PATHOGENESIS IN MYOTONIC DYSTOPHY
RNA介导的强直性肌营养不良中枢神经系统发病机制
- 批准号:
8739678 - 财政年份:2008
- 资助金额:
$ 29.74万 - 项目类别:
Preclinical models, biomarkers, and therapy for myotonic dystrophy type 1
1 型强直性肌营养不良的临床前模型、生物标志物和治疗
- 批准号:
10021453 - 财政年份:2003
- 资助金额:
$ 29.74万 - 项目类别:
Preclinical models, biomarkers, and therapy for myotonic dystrophy type 1
1 型强直性肌营养不良的临床前模型、生物标志物和治疗
- 批准号:
10480097 - 财政年份:2003
- 资助金额:
$ 29.74万 - 项目类别:
MOUSE MUSCLEBLIND MODEL FOR MYOTONIC DYSTROPHY
强直性肌营养不良小鼠肌盲模型
- 批准号:
6824697 - 财政年份:2003
- 资助金额:
$ 29.74万 - 项目类别:
Preclinical models, biomarkers, and therapy for myotonic dystrophy type 1
1 型强直性肌营养不良的临床前模型、生物标志物和治疗
- 批准号:
10237267 - 财政年份:2003
- 资助金额:
$ 29.74万 - 项目类别:
相似海外基金
Impact of alternative polyadenylation of 3'-untranslated regions in the PI3K/AKT cascade on microRNA
PI3K/AKT 级联中 3-非翻译区的替代多聚腺苷酸化对 microRNA 的影响
- 批准号:
573541-2022 - 财政年份:2022
- 资助金额:
$ 29.74万 - 项目类别:
University Undergraduate Student Research Awards
How do untranslated regions of cannabinoid receptor type 1 mRNA determine receptor subcellular localisation and function?
1 型大麻素受体 mRNA 的非翻译区如何决定受体亚细胞定位和功能?
- 批准号:
2744317 - 财政年份:2022
- 资助金额:
$ 29.74万 - 项目类别:
Studentship
MICA:Synthetic untranslated regions for direct delivery of therapeutic mRNAs
MICA:用于直接递送治疗性 mRNA 的合成非翻译区
- 批准号:
MR/V010948/1 - 财政年份:2021
- 资助金额:
$ 29.74万 - 项目类别:
Research Grant
Translational Control by 5'-untranslated regions
5-非翻译区域的翻译控制
- 批准号:
10019570 - 财政年份:2019
- 资助金额:
$ 29.74万 - 项目类别:
Translational Control by 5'-untranslated regions
5-非翻译区域的翻译控制
- 批准号:
10223370 - 财政年份:2019
- 资助金额:
$ 29.74万 - 项目类别:
Translational Control by 5'-untranslated regions
5-非翻译区域的翻译控制
- 批准号:
10455108 - 财政年份:2019
- 资助金额:
$ 29.74万 - 项目类别:
Synergistic microRNA-binding sites, and 3' untranslated regions: a dialogue of silence
协同的 microRNA 结合位点和 3 非翻译区:沉默的对话
- 批准号:
255762 - 财政年份:2012
- 资助金额:
$ 29.74万 - 项目类别:
Operating Grants
Analysis of long untranslated regions in Nipah virus genome
尼帕病毒基因组长非翻译区分析
- 批准号:
20790351 - 财政年份:2008
- 资助金额:
$ 29.74万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Search for mRNA elements involved in the compatibility between 5' untranslated regions and coding regions in chloroplast translation
寻找参与叶绿体翻译中 5 非翻译区和编码区之间兼容性的 mRNA 元件
- 批准号:
19370021 - 财政年份:2007
- 资助金额:
$ 29.74万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Post-transcriptional Regulation of PPAR-g Expression by 5'-Untranslated Regions
5-非翻译区对 PPAR-g 表达的转录后调控
- 批准号:
7131841 - 财政年份:2006
- 资助金额:
$ 29.74万 - 项目类别:














{{item.name}}会员




